STONY BROOK, NY--(Marketwired - December 08, 2015) - Applied DNA Sciences (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, will host a conference call and webcast on Tuesday, December 15, 2015 at 8:30 AM ET to discuss its fiscal fourth quarter and year-end 2015 results. The Annual Report Form 10-K will be filed with the Securities & Exchange Commission by the end of the day on Monday, December 14, 2015, and the press release will be issued prior to the call.

Dr. James Hayward, president and CEO, and Beth Jantzen, CFO, of Applied DNA Sciences, plan to discuss the company's performance and achievements and outline key ongoing and future business initiatives. The presentation will be followed by a question-and-answer session.

All participants to the conference call must pre-register using the link below. Due to the large number of expected participants, not all questions may be answered on the call.

For those investors unable to attend the live call, a copy of the presentation is expected to be posted by end of business on December 15, 2015 and available under the "Investor Information" tab of the company's web site. Conference call and webcast replay information is provided below.

To Participate:

Reserve your conference call seat now at: Conference call dial-in information will be provided at completion of the registration process.

Live webcast:

Replay (available 1 hour following the conclusion of the live call):

About Applied DNA Sciences

We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet® , our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA® , providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements

The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2015, May 11,2015 and August 10, 2015, which are available at APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contact Information:

Investor contact:
Debbie Bailey